![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1417531
¼¼°èÀÇ ÈÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤±â ½ÃÀå º¸°í¼ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®(-2030³â)Chemiluminescence Immunoassay Analyzer Market Report: Trends, Forecast and Competitive Analysis to 2030 |
ÈÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤±âÀÇ µ¿Çâ°ú Àü¸Á
ÈÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤±â ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 6.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2030³â±îÁö ¾à 200¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ±Þ¼º ¹× ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ÈÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤±â(CLIA) ±â¼ú °³¹ßÀÇ °¡¼ÓÈ, ¸¸¼º ÁúȯÀÇ Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö´Â °ÍÀÔ´Ï´Ù. ÈÇй߱¤ ¸é¿ªÃøÁ¤ Àåºñ ¼¼°è ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø, Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷, ÀÓ»ó½ÇÇè½Ç ½ÃÀå¿¡¼ÀÇ ±âȸ·Î ÀÎÇØ À¯¸ÁÇÑ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
ÈÇй߱¤ ¸é¿ª ÃøÁ¤±â ½ÃÀå ÀλçÀÌÆ®
LucintelÀº ¾Ï ȯÀÚ Áõ°¡¿Í ½ÅÈï±¹¿¡¼ÀÇ ¾Ï ¹ß°ß¿¡ ´ëÇÑ Áö½Ä Áõ°¡·Î ÀÎÇØ ¾Ï ºÐ¾ß°¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.
ºÏ¹Ì´Â ¹Ì±¹, ij³ª´Ù µîÀÇ ±¹°¡¿¡¼ ±¸Á¶ÈµÈ ÀÇ·á ÀÎÇÁ¶ó ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ¿ëÀÌÇϰí, ÈÇй߱¤ ¸é¿ª ÃøÁ¤ ÀåÄ¡ °ü·Ã ¿¬±¸ Ȱµ¿¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±ÝÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀ¸·Î ³²À» °ÍÀÔ´Ï´Ù.
Q1. ½ÃÀå ±Ô¸ð´Â?
A1. ÈÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ Àåºñ ¼¼°è ½ÃÀåÀº 2030³â±îÁö ¾à 200¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q2. ½ÃÀå ¼ºÀå Àü¸ÁÀº?
A2. ÈÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ Àåºñ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q3. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?
A3.ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ±Þ¼º ¹× ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ÈÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ ÀåÄ¡(CLIA) ±â¼ú °³¹ßÀÇ °¡¼ÓÈ, ¸¸¼º ÁúȯÀÇ Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö´Â °ÍÀÔ´Ï´Ù.
Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?
A4. ¼¼°è ÈÇй߱¤ ¸é¿ª ÃøÁ¤±â ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø, Á¦¾à ¹× ¹ÙÀÌ¿À ±â¾÷, ÀÓ»ó °Ë»ç ½ÃÀå¿¡¼ À¯¸ÁÇÕ´Ï´Ù.
Q5. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?
A5. ÈÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ Àåºñ ÁÖ¿ä ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.
Q6. ÇâÈÄ °¡Àå Å« ½ÃÀå ºÎ¹®Àº?
A6.LucintelÀº ¾Ï ȯÀÚ Áõ°¡¿Í ½ÅÈï±¹¿¡¼ÀÇ ¾Ï °ËÃâ¿¡ ´ëÇÑ Áö½Ä Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ¾Ï ºÐ¾ß°¡ ´õ Å« ºÎ¹®À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.
Q7. ÇâÈÄ 5³â°£ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº?
A7. ºÏ¹Ì´Â ¹Ì±¹, ij³ª´Ù¿Í °°Àº ±¹°¡¿¡¼ ±¸ÃàµÈ ÇコÄɾî ÀÎÇÁ¶ó ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ¿ëÀÌÇϰí, ÈÇй߱¤ ¸é¿ª ÃøÁ¤ ÀåÄ¡ °ü·Ã ¿¬±¸ Ȱµ¿¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±ÝÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀ¸·Î ³²¾ÆÀÖÀ» °ÍÀÔ´Ï´Ù.
Q8. º¸°í¼ Ä¿½ºÅ͸¶ÀÌ¡ÀÌ °¡´ÉÇѰ¡?
A8. ³×. LucintelÀº Ãß°¡ ºñ¿ë¾øÀÌ 10%ÀÇ »ç¿ëÀÚ Á¤ÀǸ¦ Á¦°øÇÕ´Ï´Ù.
Chemiluminescene Immunoassay Analyzer Trends and Forecast
The future of the global chemiluminescene immunoassay analyzer market looks promising with opportunities in the hospital, pharmaceutical & biotech firm, and clinical laboratories markets. The global chemiluminescene immunoassay analyzer market is expected to reach an estimated $20.0 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising rates of both acute and chronic illnesses, greater speed at which technology is developing for chemiluminescence immunoassay (CLIA) analyzers, as well as, the rising awareness of the importance of early identification of chronic diseases.
A more than 150-page report is developed to help in your business decisions.
Chemiluminescene Immunoassay Analyzer by Segment
The study includes a forecast for the global chemiluminescene immunoassay analyzer by product, application, end use, and region.
List of Chemiluminescene Immunoassay Analyzer Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chemiluminescene immunoassay analyzer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chemiluminescene immunoassay analyzer companies profiled in this report include-
Chemiluminescene Immunoassay Analyzer Market Insights
Lucintel forecasts that oncology will remain the larger segment over the forecast period due to increase in cancer cases and growing knowledge of its detection in emerging nations.
North America will remain the largest region over the forecast period due to the easy accessibility of well-structured healthcare infrastructure facilities in nations such as the united states and canada, as well as an increase in government funding for research efforts connected to chemiluminescence immunoassay analyzers.
Features of the Global Chemiluminescene Immunoassay Analyzer Market
Market Size Estimates: Chemiluminescene immunoassay analyzer market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Chemiluminescene immunoassay analyzer market size by product, application, end use, and region in terms of value ($B).
Regional Analysis: Chemiluminescene immunoassay analyzer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and regions for the chemiluminescene immunoassay analyzer market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chemiluminescene immunoassay analyzer market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the chemiluminescene immunoassay analyzer market size?
Answer: The global chemiluminescene immunoassay analyzer market is expected to reach an estimated $20.0 billion by 2030.
Q2. What is the growth forecast for chemiluminescene immunoassay analyzer market?
Answer: The global chemiluminescene immunoassay analyzer market is expected to grow with a CAGR of 6.6% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the chemiluminescene immunoassay analyzer market?
Answer: The major drivers for this market are rising rates of both acute and chronic illnesses, greater speed at which technology is developing for chemiluminescence immunoassay (CLIA) analyzers, as well as, the rising awareness of the importance of early identification of chronic diseases.
Q4. What are the major segments for chemiluminescene immunoassay analyzer market?
Answer: The future of the global chemiluminescene immunoassay analyzer market looks promising with opportunities in the hospital, pharmaceutical & biotech firm, and clinical laboratories markets.
Q5. Who are the key chemiluminescene immunoassay analyzer market companies?
Answer: Some of the key chemiluminescene immunoassay analyzer companies are as follows.
Q6. Which chemiluminescene immunoassay analyzer market segment will be the largest in future?
Answer: Lucintel forecasts that oncology will remain the larger segment over the forecast period due to increase in cancer cases and growing knowledge of its detection in emerging nations.
Q7. In chemiluminescene immunoassay analyzer market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the easy accessibility of well-structured healthcare infrastructure facilities in nations such as the united states and canada, as well as an increase in government funding for research efforts connected to chemiluminescence immunoassay analyzers.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.